1vjy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1vjy.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1vjy.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1vjy| PDB=1vjy | SCENE= }}
{{STRUCTURE_1vjy| PDB=1vjy | SCENE= }}
-
'''Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor'''
+
===Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor===
-
==Overview==
+
<!--
-
Optimization of the screening hit 1 led to the identification of novel 1,5-naphthyridine aminothiazole and pyrazole derivatives, which are potent and selective inhibitors of the transforming growth factor-beta type I receptor, ALK5. Compounds 15 and 19, which inhibited ALK5 autophosphorylation with IC50 = 6 and 4 nM, respectively, showed potent activities in both binding and cellular assays and exhibited selectivity over p38 mitogen-activated protein kinase. The X-ray crystal structure of 19 in complex with human ALK5 is described, confirming the binding mode proposed from docking studies.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15317461}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15317461 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15317461}}
==About this Structure==
==About this Structure==
Line 43: Line 47:
[[Category: Protein kinase]]
[[Category: Protein kinase]]
[[Category: Transferase]]
[[Category: Transferase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 12:37:10 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 09:14:30 2008''

Revision as of 06:14, 28 July 2008

Template:STRUCTURE 1vjy

Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor

Template:ABSTRACT PUBMED 15317461

About this Structure

1VJY is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors., Gellibert F, Woolven J, Fouchet MH, Mathews N, Goodland H, Lovegrove V, Laroze A, Nguyen VL, Sautet S, Wang R, Janson C, Smith W, Krysa G, Boullay V, De Gouville AC, Huet S, Hartley D, J Med Chem. 2004 Aug 26;47(18):4494-506. PMID:15317461

Page seeded by OCA on Mon Jul 28 09:14:30 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools